| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microglia | 9 | 2013 | 143 | 1.530 |
Why?
|
| Astrocytes | 10 | 2015 | 270 | 1.450 |
Why?
|
| Oligodendroglia | 11 | 2016 | 107 | 1.430 |
Why?
|
| Amyloid beta-Peptides | 3 | 2022 | 191 | 1.260 |
Why?
|
| Tumor Necrosis Factor-alpha | 13 | 2016 | 626 | 1.100 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 7 | 1999 | 107 | 1.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 6 | 2006 | 250 | 0.960 |
Why?
|
| Neuroglia | 6 | 2007 | 136 | 0.880 |
Why?
|
| Interferon-gamma | 6 | 2016 | 241 | 0.880 |
Why?
|
| Alzheimer Disease | 8 | 2020 | 565 | 0.880 |
Why?
|
| Nitric Oxide Synthase Type II | 8 | 2013 | 201 | 0.850 |
Why?
|
| PrPC Proteins | 1 | 2022 | 3 | 0.850 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 6 | 2007 | 134 | 0.760 |
Why?
|
| Neuroprotective Agents | 4 | 2015 | 317 | 0.740 |
Why?
|
| MAP Kinase Kinase Kinases | 2 | 2013 | 34 | 0.680 |
Why?
|
| Nitric Oxide Synthase | 5 | 2004 | 163 | 0.610 |
Why?
|
| Cells, Cultured | 18 | 2013 | 2673 | 0.560 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 5 | 2006 | 140 | 0.560 |
Why?
|
| Oligodendroglioma | 1 | 2016 | 18 | 0.560 |
Why?
|
| Cell Hypoxia | 2 | 2007 | 92 | 0.550 |
Why?
|
| Encephalitis | 2 | 2008 | 43 | 0.550 |
Why?
|
| Cerebrovascular Disorders | 2 | 2015 | 182 | 0.540 |
Why?
|
| Animals | 42 | 2020 | 20881 | 0.520 |
Why?
|
| Cell Death | 5 | 2022 | 329 | 0.490 |
Why?
|
| Brain | 12 | 2020 | 2176 | 0.490 |
Why?
|
| Nitric Oxide | 6 | 2013 | 382 | 0.480 |
Why?
|
| Neuritis | 1 | 2013 | 4 | 0.460 |
Why?
|
| Rats | 22 | 2013 | 5300 | 0.450 |
Why?
|
| Ceramides | 2 | 2016 | 578 | 0.450 |
Why?
|
| Lipopolysaccharides | 7 | 2013 | 455 | 0.450 |
Why?
|
| Pericytes | 3 | 2020 | 81 | 0.440 |
Why?
|
| Signal Transduction | 6 | 2013 | 2689 | 0.430 |
Why?
|
| Cholesterol, Dietary | 1 | 2013 | 22 | 0.430 |
Why?
|
| Diet, High-Fat | 1 | 2013 | 81 | 0.420 |
Why?
|
| tau Proteins | 1 | 2013 | 61 | 0.420 |
Why?
|
| Antipsychotic Agents | 1 | 2015 | 247 | 0.410 |
Why?
|
| Enzyme Inhibitors | 9 | 2011 | 659 | 0.410 |
Why?
|
| Enzyme Activation | 10 | 2007 | 791 | 0.410 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2013 | 110 | 0.410 |
Why?
|
| Minocycline | 3 | 2007 | 61 | 0.410 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2013 | 411 | 0.390 |
Why?
|
| Isoenzymes | 2 | 2006 | 308 | 0.390 |
Why?
|
| Metabolic Diseases | 1 | 2010 | 37 | 0.360 |
Why?
|
| Insulin | 1 | 2013 | 619 | 0.340 |
Why?
|
| Gene Expression | 4 | 2013 | 770 | 0.340 |
Why?
|
| Laminin | 2 | 2022 | 62 | 0.340 |
Why?
|
| Hippocampus | 1 | 2013 | 471 | 0.340 |
Why?
|
| Cholesterol | 2 | 2008 | 331 | 0.330 |
Why?
|
| NF-kappa B | 3 | 2006 | 432 | 0.330 |
Why?
|
| Memory Disorders | 3 | 2011 | 111 | 0.330 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2011 | 115 | 0.320 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2003 | 216 | 0.320 |
Why?
|
| Mice | 16 | 2020 | 8474 | 0.310 |
Why?
|
| Heart Diseases | 1 | 2010 | 276 | 0.310 |
Why?
|
| Memory, Short-Term | 1 | 2008 | 79 | 0.300 |
Why?
|
| Hypercholesterolemia | 1 | 2008 | 86 | 0.300 |
Why?
|
| Oxidative Stress | 3 | 2015 | 718 | 0.300 |
Why?
|
| Imidazoles | 6 | 2007 | 175 | 0.290 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2004 | 282 | 0.280 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 39 | 0.280 |
Why?
|
| Motor Neurons | 1 | 2007 | 98 | 0.280 |
Why?
|
| Amyloid Precursor Protein Secretases | 3 | 2013 | 59 | 0.280 |
Why?
|
| Chemokines, CXC | 1 | 2006 | 16 | 0.270 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2006 | 17 | 0.270 |
Why?
|
| Stem Cells | 5 | 1998 | 248 | 0.260 |
Why?
|
| Pyridines | 5 | 2007 | 261 | 0.250 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1996 | 195 | 0.250 |
Why?
|
| Mice, Inbred C57BL | 7 | 2015 | 2791 | 0.250 |
Why?
|
| Cytokines | 4 | 2008 | 866 | 0.250 |
Why?
|
| Myelin Sheath | 5 | 2012 | 115 | 0.250 |
Why?
|
| Phosphorylation | 6 | 2013 | 1200 | 0.240 |
Why?
|
| Gliosis | 1 | 2004 | 51 | 0.240 |
Why?
|
| Oxygen | 1 | 2006 | 386 | 0.230 |
Why?
|
| NADPH Oxidases | 1 | 2004 | 80 | 0.230 |
Why?
|
| Capillaries | 3 | 2020 | 105 | 0.220 |
Why?
|
| Receptors, Laminin | 1 | 2022 | 4 | 0.210 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2022 | 5 | 0.210 |
Why?
|
| Prion Proteins | 1 | 2022 | 4 | 0.210 |
Why?
|
| MAP Kinase Signaling System | 3 | 2013 | 247 | 0.210 |
Why?
|
| Gene Expression Regulation | 2 | 2006 | 1293 | 0.200 |
Why?
|
| RNA, Messenger | 6 | 2007 | 1664 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2009 | 710 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 3 | 2005 | 290 | 0.190 |
Why?
|
| Blood-Brain Barrier | 2 | 2020 | 99 | 0.190 |
Why?
|
| Protein Kinases | 2 | 1999 | 122 | 0.190 |
Why?
|
| Animals, Newborn | 6 | 2006 | 396 | 0.180 |
Why?
|
| Blotting, Western | 4 | 2007 | 954 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 1026 | 0.180 |
Why?
|
| Cell Line | 5 | 2007 | 1752 | 0.180 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2020 | 20 | 0.180 |
Why?
|
| Insulin Resistance | 2 | 2013 | 241 | 0.170 |
Why?
|
| Endothelium | 1 | 2020 | 98 | 0.170 |
Why?
|
| Crystallins | 1 | 1999 | 9 | 0.170 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2016 | 381 | 0.170 |
Why?
|
| Oxidants | 1 | 1999 | 48 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 1999 | 82 | 0.160 |
Why?
|
| Hydrogen Peroxide | 1 | 1999 | 168 | 0.150 |
Why?
|
| Neurons | 4 | 2013 | 881 | 0.150 |
Why?
|
| Microvessels | 1 | 2017 | 43 | 0.150 |
Why?
|
| Hyaluronic Acid | 2 | 2012 | 206 | 0.140 |
Why?
|
| Extracellular Vesicles | 1 | 2016 | 21 | 0.140 |
Why?
|
| Anthracenes | 2 | 2006 | 26 | 0.140 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2017 | 144 | 0.140 |
Why?
|
| Exosomes | 1 | 2016 | 44 | 0.130 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2016 | 139 | 0.130 |
Why?
|
| Hypothalamus, Posterior | 1 | 2015 | 6 | 0.130 |
Why?
|
| Optogenetics | 1 | 2015 | 20 | 0.130 |
Why?
|
| Thrombin | 1 | 1995 | 117 | 0.130 |
Why?
|
| RNA, Small Interfering | 2 | 2007 | 434 | 0.120 |
Why?
|
| Swainsonine | 1 | 1994 | 1 | 0.120 |
Why?
|
| Glucosidases | 1 | 1994 | 4 | 0.120 |
Why?
|
| Indolizines | 1 | 1994 | 3 | 0.120 |
Why?
|
| Oligosaccharides | 1 | 1994 | 26 | 0.120 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 1994 | 22 | 0.120 |
Why?
|
| Endothelial Cells | 1 | 2018 | 384 | 0.120 |
Why?
|
| Mice, Knockout | 3 | 2010 | 1692 | 0.120 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 415 | 0.120 |
Why?
|
| Disease Models, Animal | 5 | 2011 | 2550 | 0.120 |
Why?
|
| Diet | 2 | 2010 | 514 | 0.120 |
Why?
|
| Protein Biosynthesis | 1 | 1995 | 181 | 0.120 |
Why?
|
| Demyelinating Diseases | 2 | 2012 | 57 | 0.110 |
Why?
|
| Maze Learning | 3 | 2011 | 138 | 0.110 |
Why?
|
| Sphingolipids | 1 | 2016 | 337 | 0.110 |
Why?
|
| Sleep | 1 | 2015 | 263 | 0.110 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2010 | 71 | 0.110 |
Why?
|
| Sirtuin 1 | 1 | 2013 | 47 | 0.110 |
Why?
|
| Transfection | 2 | 2006 | 782 | 0.110 |
Why?
|
| Humans | 14 | 2016 | 68618 | 0.110 |
Why?
|
| Neural Stem Cells | 1 | 2012 | 32 | 0.110 |
Why?
|
| Aspartic Acid Endopeptidases | 2 | 2013 | 47 | 0.110 |
Why?
|
| PPAR gamma | 1 | 2013 | 95 | 0.100 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 58 | 0.100 |
Why?
|
| Hydrogels | 1 | 2012 | 54 | 0.100 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1994 | 284 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 1998 | 150 | 0.100 |
Why?
|
| Myelin Basic Protein | 2 | 2007 | 62 | 0.100 |
Why?
|
| Apoptosis | 1 | 1998 | 1641 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2011 | 507 | 0.100 |
Why?
|
| Stress, Physiological | 1 | 2013 | 215 | 0.100 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 1851 | 0.100 |
Why?
|
| Cell Differentiation | 3 | 2007 | 1034 | 0.100 |
Why?
|
| Enzyme Induction | 2 | 2003 | 119 | 0.090 |
Why?
|
| Plaque, Amyloid | 1 | 2011 | 31 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2005 | 2083 | 0.090 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2010 | 52 | 0.090 |
Why?
|
| Pregnancy | 2 | 2013 | 2334 | 0.090 |
Why?
|
| Glucose | 2 | 2007 | 307 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 1995 | 617 | 0.090 |
Why?
|
| Substantia Nigra | 1 | 2010 | 102 | 0.090 |
Why?
|
| Up-Regulation | 2 | 2013 | 682 | 0.090 |
Why?
|
| Cholecalciferol | 1 | 2011 | 143 | 0.090 |
Why?
|
| Gene Library | 1 | 2009 | 68 | 0.090 |
Why?
|
| Neurodegenerative Diseases | 1 | 2010 | 102 | 0.090 |
Why?
|
| Genes | 1 | 2009 | 86 | 0.090 |
Why?
|
| Mammals | 1 | 2009 | 47 | 0.090 |
Why?
|
| NG-Nitroarginine Methyl Ester | 2 | 1999 | 23 | 0.080 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2010 | 154 | 0.080 |
Why?
|
| DNA, Complementary | 1 | 2009 | 251 | 0.080 |
Why?
|
| Risk | 1 | 2010 | 563 | 0.080 |
Why?
|
| Cloning, Molecular | 1 | 2009 | 357 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2013 | 753 | 0.080 |
Why?
|
| Diabetes Complications | 1 | 2010 | 249 | 0.080 |
Why?
|
| Tetradecanoylphorbol Acetate | 3 | 2005 | 138 | 0.080 |
Why?
|
| Arterioles | 2 | 2020 | 40 | 0.080 |
Why?
|
| Metabolic Syndrome | 1 | 2010 | 191 | 0.080 |
Why?
|
| Life Style | 1 | 2010 | 338 | 0.080 |
Why?
|
| Atherosclerosis | 1 | 2010 | 204 | 0.080 |
Why?
|
| Receptors, LDL | 1 | 2008 | 72 | 0.080 |
Why?
|
| Dietary Fats | 1 | 2008 | 103 | 0.080 |
Why?
|
| Computational Biology | 1 | 2009 | 190 | 0.080 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2007 | 67 | 0.070 |
Why?
|
| Glycosphingolipids | 1 | 2007 | 51 | 0.070 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2007 | 7 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 2 | 2013 | 615 | 0.070 |
Why?
|
| Immunoblotting | 2 | 1999 | 254 | 0.070 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2007 | 20 | 0.070 |
Why?
|
| Colforsin | 1 | 2007 | 42 | 0.070 |
Why?
|
| Mixed Function Oxygenases | 1 | 2006 | 35 | 0.070 |
Why?
|
| Chemokine CXCL10 | 1 | 2006 | 21 | 0.070 |
Why?
|
| Spinal Cord Injuries | 1 | 2012 | 551 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2007 | 489 | 0.070 |
Why?
|
| Heme Oxygenase-1 | 1 | 2006 | 40 | 0.070 |
Why?
|
| Luciferases | 1 | 2006 | 105 | 0.070 |
Why?
|
| Central Nervous System Diseases | 1 | 2006 | 40 | 0.070 |
Why?
|
| Peptide Fragments | 1 | 2008 | 483 | 0.070 |
Why?
|
| Male | 9 | 2020 | 37321 | 0.070 |
Why?
|
| Female | 8 | 2020 | 38074 | 0.070 |
Why?
|
| Parkinsonian Disorders | 1 | 2006 | 43 | 0.070 |
Why?
|
| Fatty Acids | 1 | 2006 | 222 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2006 | 107 | 0.060 |
Why?
|
| Sphingosine | 1 | 2007 | 315 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2006 | 289 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 175 | 0.060 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2004 | 9 | 0.060 |
Why?
|
| Membrane Transport Proteins | 1 | 2005 | 81 | 0.060 |
Why?
|
| Cholinergic Fibers | 1 | 2004 | 27 | 0.060 |
Why?
|
| Immunotoxins | 1 | 2004 | 23 | 0.060 |
Why?
|
| Prosencephalon | 1 | 2004 | 38 | 0.060 |
Why?
|
| Plant Proteins | 1 | 2004 | 48 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2006 | 1040 | 0.060 |
Why?
|
| Behavior, Animal | 1 | 2006 | 470 | 0.060 |
Why?
|
| Interleukin-1 | 2 | 2004 | 86 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2004 | 567 | 0.050 |
Why?
|
| Inflammation Mediators | 1 | 2004 | 244 | 0.050 |
Why?
|
| Transcriptional Activation | 1 | 2003 | 226 | 0.050 |
Why?
|
| Immunohistochemistry | 3 | 2006 | 1174 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 370 | 0.050 |
Why?
|
| Environmental Exposure | 1 | 2004 | 269 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 1033 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2004 | 499 | 0.050 |
Why?
|
| Age Factors | 2 | 2020 | 1864 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2003 | 597 | 0.040 |
Why?
|
| Hypercapnia | 1 | 2020 | 17 | 0.040 |
Why?
|
| Brain Chemistry | 2 | 1998 | 173 | 0.040 |
Why?
|
| Nitrites | 1 | 1999 | 53 | 0.040 |
Why?
|
| Protein Kinase C | 2 | 2005 | 270 | 0.040 |
Why?
|
| Cytotoxins | 1 | 1999 | 23 | 0.040 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 1998 | 24 | 0.040 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 1999 | 33 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 1999 | 85 | 0.040 |
Why?
|
| Alleles | 1 | 2020 | 386 | 0.040 |
Why?
|
| Caspase Inhibitors | 1 | 1998 | 36 | 0.040 |
Why?
|
| fas Receptor | 1 | 1998 | 54 | 0.040 |
Why?
|
| Culture Media | 1 | 1999 | 155 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 1999 | 246 | 0.040 |
Why?
|
| Protease Inhibitors | 1 | 1998 | 76 | 0.040 |
Why?
|
| Caspases | 1 | 1998 | 194 | 0.040 |
Why?
|
| Flavonoids | 1 | 1999 | 109 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 147 | 0.040 |
Why?
|
| Drug Synergism | 1 | 1998 | 260 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2020 | 296 | 0.040 |
Why?
|
| Receptors, Drug | 1 | 1998 | 31 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 1998 | 11 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2013 | 447 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 492 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 1998 | 742 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 337 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 272 | 0.030 |
Why?
|
| Mitogens | 1 | 1996 | 45 | 0.030 |
Why?
|
| Actins | 1 | 2017 | 249 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 1996 | 64 | 0.030 |
Why?
|
| Growth Substances | 1 | 1996 | 77 | 0.030 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1995 | 60 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1553 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1996 | 93 | 0.030 |
Why?
|
| Precipitin Tests | 1 | 1995 | 88 | 0.030 |
Why?
|
| Radioligand Assay | 1 | 1995 | 109 | 0.030 |
Why?
|
| Pertussis Toxin | 1 | 1995 | 72 | 0.030 |
Why?
|
| Sleep, REM | 1 | 2015 | 93 | 0.030 |
Why?
|
| Myristoylated Alanine-Rich C Kinase Substrate | 1 | 1995 | 3 | 0.030 |
Why?
|
| Tyrosine | 1 | 1995 | 196 | 0.030 |
Why?
|
| alpha-Mannosidase | 1 | 1994 | 2 | 0.030 |
Why?
|
| alpha-Glucosidases | 1 | 1994 | 2 | 0.030 |
Why?
|
| 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase | 1 | 1994 | 3 | 0.030 |
Why?
|
| Mannosidases | 1 | 1994 | 4 | 0.030 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 1996 | 183 | 0.030 |
Why?
|
| Mannose | 1 | 1994 | 9 | 0.030 |
Why?
|
| 2',3'-Cyclic-Nucleotide Phosphodiesterases | 1 | 1994 | 18 | 0.030 |
Why?
|
| Glycoside Hydrolase Inhibitors | 1 | 1994 | 7 | 0.030 |
Why?
|
| Nerve Degeneration | 2 | 2006 | 134 | 0.030 |
Why?
|
| Antigens, Differentiation | 1 | 1994 | 49 | 0.030 |
Why?
|
| Glycosylation | 1 | 1994 | 185 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 1995 | 261 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 1994 | 148 | 0.030 |
Why?
|
| Cell Division | 1 | 1994 | 541 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2013 | 51 | 0.030 |
Why?
|
| Rats, Nude | 1 | 2012 | 5 | 0.030 |
Why?
|
| Acetylation | 1 | 2013 | 94 | 0.030 |
Why?
|
| Gelatin | 1 | 2012 | 14 | 0.030 |
Why?
|
| Rabbits | 2 | 2007 | 509 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2012 | 242 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2013 | 102 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2012 | 149 | 0.020 |
Why?
|
| Axons | 1 | 2012 | 139 | 0.020 |
Why?
|
| Fibroblasts | 1 | 1996 | 902 | 0.020 |
Why?
|
| NFI Transcription Factors | 1 | 2011 | 6 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 562 | 0.020 |
Why?
|
| Presenilin-1 | 1 | 2011 | 28 | 0.020 |
Why?
|
| Nerve Growth Factor | 1 | 2011 | 54 | 0.020 |
Why?
|
| Neostriatum | 1 | 2010 | 60 | 0.020 |
Why?
|
| Heterozygote | 1 | 2010 | 174 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2011 | 145 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2009 | 109 | 0.020 |
Why?
|
| Biomarkers | 1 | 1994 | 1593 | 0.020 |
Why?
|
| Dopamine | 1 | 2010 | 474 | 0.020 |
Why?
|
| Gerbillinae | 1 | 2007 | 156 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 127 | 0.020 |
Why?
|
| Galactolipids | 1 | 2006 | 4 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 1745 | 0.020 |
Why?
|
| DNA | 1 | 2009 | 597 | 0.020 |
Why?
|
| Hydroxylation | 1 | 2006 | 41 | 0.020 |
Why?
|
| Adrenergic Agents | 1 | 2006 | 14 | 0.020 |
Why?
|
| Oxidopamine | 1 | 2006 | 42 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2006 | 104 | 0.020 |
Why?
|
| DNA Primers | 1 | 2006 | 302 | 0.020 |
Why?
|
| Syntaxin 1 | 1 | 2005 | 6 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2005 | 71 | 0.020 |
Why?
|
| Membrane Microdomains | 1 | 2005 | 32 | 0.020 |
Why?
|
| Synaptosomes | 1 | 2005 | 57 | 0.020 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2005 | 51 | 0.020 |
Why?
|
| Base Sequence | 1 | 2006 | 1015 | 0.020 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2005 | 67 | 0.020 |
Why?
|
| Protein Phosphatase 2 | 1 | 2005 | 67 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 2004 | 50 | 0.010 |
Why?
|
| Serotonin | 1 | 2005 | 144 | 0.010 |
Why?
|
| Ribosome Inactivating Proteins, Type 1 | 1 | 2004 | 21 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 1083 | 0.010 |
Why?
|
| Endocytosis | 1 | 2005 | 113 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 2004 | 75 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 1447 | 0.010 |
Why?
|
| Protein Transport | 1 | 2005 | 280 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 689 | 0.010 |
Why?
|
| Calcium | 1 | 2005 | 929 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2004 | 848 | 0.010 |
Why?
|
| Schistosoma japonicum | 1 | 1998 | 2 | 0.010 |
Why?
|
| Receptors, Cannabinoid | 1 | 1998 | 26 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1998 | 98 | 0.010 |
Why?
|
| CHO Cells | 1 | 1998 | 161 | 0.010 |
Why?
|
| Cricetinae | 1 | 1998 | 262 | 0.010 |
Why?
|
| Mice, Jimpy | 1 | 1997 | 5 | 0.010 |
Why?
|
| Cerebrosides | 1 | 1997 | 13 | 0.010 |
Why?
|
| Immunochemistry | 1 | 1997 | 17 | 0.010 |
Why?
|
| Mice, Quaking | 1 | 1997 | 12 | 0.010 |
Why?
|
| United States | 1 | 2009 | 7367 | 0.010 |
Why?
|
| Chromatography, Gas | 1 | 1997 | 31 | 0.010 |
Why?
|
| Cannabinoids | 1 | 1998 | 90 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 1997 | 52 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1998 | 231 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1998 | 376 | 0.010 |
Why?
|
| Risk Factors | 1 | 2004 | 5731 | 0.010 |
Why?
|
| Macrophages | 1 | 1998 | 647 | 0.010 |
Why?
|